Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 1;72(12):1704-1713.
doi: 10.4103/IJO.IJO_30_24. Epub 2024 Aug 14.

Vitrectomy for cases of diabetic retinopathy

Affiliations
Review

Vitrectomy for cases of diabetic retinopathy

Nawazish Shaikh et al. Indian J Ophthalmol. .

Abstract

Microvascular complications of diabetic retinopathy (DR) may require surgical intervention in the form of vitrectomy. Since its inception, diabetic vitrectomy has evolved with introduction of better instruments, newer techniques, and smaller port sizes. Common indications for diabetic vitrectomy include nonresolving vitreous hemorrhage, tractional retinal detachment, epiretinal membrane, progression of fibrovascular membranes despite laser therapy, recalcitrant diabetic macular edema, and neovascular glaucoma. Preoperative systemic stabilization is essential prior to planning surgery. Surgical techniques commonly used in diabetic vitrectomy are segmentation, delamination, and rarely en-bloc dissection. Modification in surgical techniques such as chandelier-assisted bimanual dissection and pharmacological adjuvants improve surgical outcomes in these patients. Prognosis in these patients could be improved with early intervention. Studies evaluating the outcome of vitrectomy in patients with early proliferative DR are required to understand the appropriate time of intervention in patients. Treatment aimed at arresting the progression of DR and gene therapy are avenues that need further evaluation. The following review will focus on covering the epidemiology of DR, indications of vitrectomy, preoperative considerations, surgical procedures of diabetic vitrectomy, methods of membrane dissection, pharmacological adjuvants to vitrectomy, outcomes of diabetic vitrectomy, and future directions of diabetic vitrectomy.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Segmentation of thick membranes at the posterior pole. Use of 25-gauge vitrectomy cutter to divide the diffuse membrane into smaller and smaller segments such that they can be safely removed
Figure 2
Figure 2
Delamination of fibrovascular membranes at the posterior pole. Pegs of fibrous membrane attached to underlying retina (blue arrows, a). Utilization of horizontal scissors and forceps coupled with chandelier illumination to dissect all the fibrous pegs (focal attachments) from underlying retina. Vitrectomy cutter can also be used in place of horizontal scissors (b). Total release of membrane followed by removal with the use of 25-gauge vitrectomy cutter (c)
Figure 3
Figure 3
Combination of various steps of diabetic vitrectomy. Use of 25-gauge vitreous cutter to make an opening in the posterior hyaloid (a). Bimanual dissection of posterior fibrous membranes using 25-gauge curved scissors and forceps coupled with chandelier illumination (b). Segmentation of fibrous membranes employing a 25-Gauge Vitreous Cutter (c). Postoperative color photograph showing residual membranes in the periphery with an attached posterior pole (d)
Figure 4
Figure 4
Preoperative ultrawide field color photograph of left eye of a patient with partially lasered PDR with tractional diabetic macular edema (a) and corresponding OCT showing distortion and thickening of retinal layers due to tractional component (b). Postoperative ultrawide field color photograph of left eye of the same patient showing tightly adherent residual fibrous membrane at disc with well-lasered and attached retina (c) and corresponding OCT showing residual disruption of retinal layers (d)
Figure 5
Figure 5
Flow chart of management of diabetic TRD with vitrectomy

References

    1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. - PMC - PubMed
    1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. - PubMed
    1. Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology. 2021;128:1580–91. - PubMed
    1. Steinmetz JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9:e144–60. - PMC - PubMed
    1. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64. - PMC - PubMed